BioSpace Events

Taking an early proof of concept into preclinical and clinical development is a costly and complex process. But there are strategic ways to streamline the process and reduce risk and costs. In this webinar, you’ll hear directly from Nobel Laureate Sir Michael Houghton and experts from Applied Pharma, who bring decades of real-world success and deep scientific expertise.

In this webinar, leading oncology experts Dr. Javier Cortés and Dr. Antonio Llombart-Cussac will explore how collaborative-initiated trials are transforming the clinical research landscape and creating new opportunities for scientific and clinical impact.

Generative AI pilots are now common in biopharma, but scaling these innovations enterprise-wide is where most teams stall. In this webinar hosted by Patsnap, we’ll share practical examples of how leading biopharma companies are unlocking real value across the R&D and commercialization value chain. You’ll also see how a top R&D spender broke down silos across multidisciplinary teams through the power of data, validated generative AI, and human-in-the-loop approaches that ensure responsible, ethical use.

Artificial intelligence is rapidly reshaping the life sciences, from automating repetitive tasks to enabling advanced scientific and safety assessments across drugs, biologics, and devices. As adoption grows across regulators, pharmaceutical companies, technology developers, nonprofits, and collaborative consortia, the need for clear, risk-based frameworks for validation, governance and human oversight becomes increasingly critical.